The history of smart contact lenses is, so far, a history of ambitious promises meeting harder-than-expected engineering realities. Google’s Verily announced a glucose-monitoring smart contact lens in 2014 that would measure blood sugar through tears, removing the need for finger-prick testing for diabetics. The project attracted enormous media attention, a partnership with Novartis, and years of development — before being quietly discontinued when the technical challenges of reliably correlating tear glucose levels to blood glucose levels proved more intractable than anticipated. Mojo Vision spent years and hundreds of millions of dollars developing a contact lens with a built-in microLED display, announced partnerships and prototypes, and then shut down its AR contact lens program in 2022 after running out of funding.
These are not reasons to dismiss the technology. They are reasons to be precise about what it requires and what is actually being demonstrated — and to separate the two distinct capability tracks: health sensing in contact lenses, which is closer to practical reality, and augmented reality display in contact lenses, which remains further away.
What Health Monitoring Has Achieved
The science of contact lens biosensing has advanced substantially from where Google’s Verily project encountered its core problem. The fundamental challenge Verily faced — that glucose levels in tears lag blood glucose levels by 10 to 30 minutes, making real-time monitoring unreliable — has been partially addressed through compensation algorithms that account for the lag and improve correlation accuracy.
More importantly, the platform for electronics integration in soft contact lenses has matured. A landmark proof-of-concept published in Science Advances by researchers at UNIST and Sungkyunkwan University demonstrated a flexible smart contact lens with integrated wireless circuits, a glucose sensor in a serpentine mesh architecture, and a micro-LED display that could indicate sensor readings to the wearer. The key innovation was the “island-bridge” architecture: rigid electronic components isolated into small islands, interconnected by stretchable serpentine conductors, with soft elastic material filling the spaces between. This design distributes mechanical strain during blinking and movement, preventing the cracking and delamination that plagued earlier rigid-component designs.
A 2025 review in the European Medical Journal documented the current landscape of smart contact lens biosensors, noting that tear fluid contains glucose, lactate, urea, proteins, and other biomarkers that change with systemic conditions, and that electrochemical sensing approaches integrated into soft contact lenses have demonstrated detection of multiple biomarkers simultaneously. A 2025 review in Eyes on Eye Care documented active development of smart contact lenses for intraocular pressure monitoring — for glaucoma management — drug delivery for glaucoma treatment, and combined glucose sensing and diabetic retinopathy treatment, all at prototype or early clinical testing stages.
At MWC 2025, Dubai-based XPANCEO unveiled three smart contact lens prototypes demonstrating wireless power transfer (charging through the air without contact), intraocular pressure sensing using an AI-powered smartphone app interface, and a new integrated microdisplay — its AR capability now featuring an integrated display rather than requiring an external image source. The company’s demonstrations represent the current frontier of multi-capability integration in a soft contact lens form factor, with explicit commercial development pathways for each capability.
The Augmented Reality Display Challenge
The health monitoring and AR display aspects of smart contact lenses face fundamentally different engineering challenges. For health monitoring, the core problem is miniaturizing known sensor chemistries into a biocompatible, flexible package and establishing wireless data transmission — difficult but tractable engineering. For AR display, the problem is optical: projecting an image onto the retina from a display element embedded in a contact lens positioned directly on the cornea, in a way that produces a focused, usable image.
The optical challenge is more fundamental than a miniaturization problem. A display element on the cornea is essentially at the focal plane of the eye’s optical system, which means conventional display optics do not apply. Getting coherent light from a micro-LED or micro-laser embedded in the lens to form a focused image on the retina requires either holographic optics or diffractive elements that add substantial fabrication complexity. XPANCEO’s integrated microdisplay approach represents progress in this direction, but the images demonstrable in prototypes are currently limited in resolution and field of view compared to even modest AR glasses.
The power problem compounds the display challenge. A micro-LED display requires substantially more power than a passive sensor, and contact lenses cannot carry large batteries. Wireless power transfer — demonstrated by XPANCEO — provides one pathway, but the energy transfer efficiency and the safe power levels for a device directly on the eye are constrained. Thermal management is also critical: even small amounts of heating in a contact lens can be uncomfortable and potentially harmful to corneal tissue.
The Navigation and Translation Vision
The full vision described in this idea — AR overlays for navigation cues, real-time translation of text or speech displayed in the field of view, health data shown as ambient information without requiring a device to be held or worn conspicuously — represents a genuinely compelling human-computer interaction model. The appeal is not merely convenience but naturalness: digital information available in the normal field of view, without the social awkwardness of glasses or the attention demands of a phone.
This vision remains years from practical reality at the capability level the opening describes. Navigation cues require a display with sufficient resolution and field of view to show meaningful spatial information — beyond what current contact lens displays can provide. Real-time translation requires not only display capability but also audio processing for spoken language, camera capability for text recognition, and AI processing — all coordinated from a device that sits on the surface of the eye. The integration of these capabilities in a single contact lens form factor, with sufficient battery life, safety, and comfort for all-day wear, represents a roadmap that current prototypes are far from completing.
What the Realistic Near-Term Trajectory Looks Like
The most credible near-term commercial applications for smart contact lenses are the health monitoring capabilities, not the AR display capabilities. Continuous glucose monitoring in a contact lens would address a genuine clinical need for diabetics who currently manage blood sugar through finger-prick testing or subcutaneous continuous glucose monitors. Intraocular pressure monitoring for glaucoma patients could detect dangerous pressure spikes that currently go unnoticed between clinic visits. Drug delivery for chronic eye conditions offers therapeutic advantages over eye drops that are largely lost through blinking.
These health applications have clearer regulatory pathways, more tractable technical requirements, and established commercial markets — the continuous glucose monitor market alone is valued at several billion dollars annually. AR display applications face harder technical problems, less clear regulatory status, and market development challenges: consumers must be convinced to wear electronic devices on their corneas for applications where glasses or phones are adequate substitutes.
What Remains Genuinely Challenging
Long-term biocompatibility of electronic components in contact lenses has not been established for all-day, multi-year wear. Corneal tissue requires oxygen, and even conventional soft contact lenses reduce oxygen transmission to some degree — adding electronics and coatings further constrains the oxygen permeability that determines safe extended wear duration. The heat management challenge for any powered device on the corneal surface is real and not yet solved at the power levels AR displays require. Regulatory approval for medical sensing devices worn on the eye will require extensive safety data, particularly for pediatric populations and continuous long-term exposure. And the hygiene and handling complexity of smart contact lenses — which will be more fragile and expensive than conventional lenses — may limit adoption to populations with strong medical motivation.
Why It Matters
The interface through which people access digital information determines how naturally that information integrates with daily experience. Smartphones changed the interface paradigm from desktop computers; wearables began pushing it toward the body. Contact lenses represent the most intimate possible interface — indistinguishable from a vision correction device, invisible to observers, positioned at the primary sensory organ through which humans engage with the world. Whether this intimacy serves primarily medical purposes, information augmentation, or both depends on which engineering problems get solved first. The health monitoring applications are more tractable and will likely arrive sooner. The full AR vision may follow, or it may find its niche in specific professional or medical applications rather than mass-market adoption. Both outcomes represent meaningful advances in how technology serves human experience at the most personal level.
Closing Human Dimension
The moment when glasses became invisible — when a person put on corrective lenses and forgot they were wearing them — was not just a convenience improvement. It changed the relationship between a corrective device and the person wearing it, from something endured to something forgotten. Smart contact lenses aim for the same disappearing act: technology that extends human capability at a level so intimate that it feels less like using a device and more like having a slightly better version of one’s own senses. For the diabetic who no longer needs to prick their finger, or the traveler who reads a foreign menu without pulling out a phone, or the glaucoma patient whose eye pressure is continuously monitored without any conscious effort — that disappearing act is the point.
Sources
1. Park, J. et al. (2018). “Soft, smart contact lenses with integrations of wireless circuits, glucose sensors, and displays.” Science Advances 4(1):eaap9841. https://pmc.ncbi.nlm.nih.gov/articles/PMC5817935/ — foundational UNIST island-bridge architecture paper.
2. “Emerging Smart Contact Lens Technology for Wearable Biosensors and Drug Delivery: Biomarkers in Tears.” European Medical Journal Innovations (2025). https://www.emjreviews.com/innovations/article/emerging-smart-contact-lens-technology-for-wearable-biosensors-and-drug-delivery-biomarkers-in-tears/
3. “Smart Contact Lenses: A Focus on the Future.” Eyes on Eye Care (November 2024 / July 2025). https://eyesoneyecare.com/resources/smart-contact-lenses-focus-on-the-future/ and https://www.eyesonhayden.com/post/smart-contact-lenses-a-focus-on-the-future
4. TechRadar. “These smart contact lens prototypes could convince future me to ditch my glasses.” (March 2025). https://www.techradar.com/health-fitness/these-smart-contact-lens-prototypes-could-convince-future-me-to-ditch-my-glasses-thanks-to-wireless-power-transfer-and-eye-health-biosensing — documents XPANCEO MWC 2025 prototypes.
5. IEEE Spectrum. “Smart Contact Lens Doubles as Blood-Sugar Monitor.” https://spectrum.ieee.org/smart-contact-lenses-get-practical — documents Verily discontinuation and UNIST design improvements.
6. “Wearable Smart Contact Lenses for Continual Glucose Monitoring: A Review.” PubMed / PMC (2022). https://pubmed.ncbi.nlm.nih.gov/35445050/
Idea generated by Grok. Article expanded with Grok, substantially rewritten with Claude Sonnet 4.6. Published at artificialideas.org.
Artificial Ideas 